References
- Ruzicka T, Bieber T, Schöpf E, et al. A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med. 1997; 337: 816–821.
- Williams HC. Atopic dermatitis. N Engl J Med. 2005; 352(22): 2314–2324.
- National Institute for Health and Clinical Excellence. Frequency of application of topical costicosteroids for atopic eczema. Technology Appraisal 81 [homepage on the Internet]. Available from: http://guidance.nice.org.uk
- Jordaan HF, Visser WI. The diagnosis and management of atopic dermatitis. S Afr Fam Pract. 2009; 51(5): 368–374.
- Buys LM. Treatment options for atopic dermatitis. Am Fam Physician. 2007; 75: 523–528 [homepage on the Internet]. Available from: http://www.aafp.org/afp
- Edelstein JA, Sinert RH. Dermatitis, atopic. eMedicine. 2009 [homepage on the Internet]. c2010. Available from: http://emedicine.medscape.com/article/762045-print
- Correale C, Walker C, Murphy L, Craig T. Atopic dermatitis: a review of diagnosis and treatment. Am Fam Physician. 1999; 60: 1191–1210 [homepage on the Internet]. c2010. Available from: http://www.aafp.org/afp/990915ap.html
- Hernandez RG, Cohen BA. Insect bite-induced hypersensitivity and the SCRATCH principles: a new approach to papular urticaria. Pediatrics. 2006; 118(1) e183- 190 [homepage on the Internet]. Available from: http://www.pediatrics.org/cgi/content/full/peds.5005-2550v1
- Kapp A, Allen BR, Reitamo S. Atopic dermatitis management with tacrolimus ointment (Protopic®). J Dermatolog Treat. 2003; 14(Suppl 1): 5–16.
- Cheer SM, Plosker GL. Tacrolimus ointment: a review of its therapeutic potential as a topical therapy in atopic dermatitis. Am J Clin Dermatol. 2001; 2(6): 389–406.
- Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis. J Am Acad Dermatol. 2004; 50: 391–404 [homepage on the Internet]. Available from: http://www.aad.org/research/_doc/ClinicalResearch_atopic%20Dermatitis%20Part%201.pdf
- Goldstein BG, Goldstein AO. General principles of dermatologic therapy and topical corticosteroid use. UptoDate [homepage on the Internet]. c2010. Available from: http://www.uptodate.com
- Rossiter D, editor. South African Medicines Formulary (SAMF). 9th edition. Cape Town: Health and Medical Publishing Group, 2010; p. 198–200, 213–214.
- Eczema guide. Topical corticosteroids [homepage on the Internet]. c2010. Available from: http://www.eczemaquide.ca/medical_treatment/topical/topical_corticosteroids.html
- Pascual JC, Fleischer AB. Tacrolimus ointment (Protopic®) for atopic dermatitis. Skin Therapy Lett. 2004; 9 [homepage on the Internet]. Available from: http://www.skintherapyletter.com/2004/9.9/1.html
- Nakagawa H. Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis. Clin Drug Invest. 2006; 26(5): 235–246.
- Reitamo S, Ortonne JP, Sand C, et al. A multicentre, randomised, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment is adults with moderate to severe atopic dermatitis. Br J Dermatol. 2005; 152: 1282–1289.
- Conroy S. New products for eczema. Arch Dis Child Educ Pract Ed. 2004; 89:ep23–26 [homepage on the Internet]. Available from: http://ep.bmj.com
- US Food and Drug Administration. Safety: elidel (pimecrolimus), protopic (tacrolimus)[homepageon the Internet]. c2010. Availablefrom: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm151161.htm
- Monthly Index of Medical Specialities (MIMS). 2010; 50(7).
- National Institute for Health and Clinical Excellence. Tacrolimus and pimecrolimus for atopic eczema. Technology Appraisal 82 [homepage on the Internet]. Available from: http://guidance.nice.org.uk/